{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:35Z","timestamp":1707524495691},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,29]]},"DOI":"10.7759\/cureus.23595","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:17:41Z","timestamp":1648545461000},"source":"Crossref","is-referenced-by-count":0,"title":["A Favorable Outcome of Grade 3 Follicular Lymphoma Treated With Surgery and Obinutuzumab Combined With Chemotherapy: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Erinie","family":"Mekheal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke E","family":"Kania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Mekheal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Bondili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maroules","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2255-4823(11)70019-4","article-title":"World Health Organization classification of tumors of hematopoietic and lymphoid tissues, 4th edition, 2008 - major changes from the 3rd edition, 2001","volume":"57","author":"Nogueira Zerbini MC","year":"2011","unstructured":"Nogueira Zerbini MC, Soares FA, Pereira Velloso ED, Chaufaille MD, Paes RP. World Health Organization classification of tumors of hematopoietic and lymphoid tissues, 4th edition, 2008 - major changes from the 3rd edition, 2001. Rev Assoc Med Bras (English Edition). 2011, 57:66-73. 10.1016\/S2255-4823(11)70019-4","journal-title":"Rev Assoc Med Bras (English Edition)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90742-0","article-title":"Gastrointestinal lymphoma in adults: clinical features and management of 300 cases","volume":"106","author":"Amer MH","year":"1994","unstructured":"Amer MH, el-Akkad S. Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology. 1994, 106:846-58. 10.1016\/0016-5085(94)90742-0","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930600109","article-title":"Primary gastrointestinal lymphoma: 30-year experience at the Cancer Institute, Madras, India","volume":"60","author":"Chandran RR","year":"1995","unstructured":"Chandran RR, Raj EH, Chaturvedi HK. Primary gastrointestinal lymphoma: 30-year experience at the Cancer Institute, Madras, India. J Surg Oncol. 1995, 60:41-9. 10.1002\/jso.2930600109","journal-title":"J Surg Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg168","article-title":"Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review","volume":"14","author":"Damaj G","year":"2003","unstructured":"Damaj G, Verkarre V, Delmer A, et al.. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol. 2003, 14:623-9. 10.1093\/annonc\/mdg168","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.18.3861","article-title":"Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01\/92","volume":"19","author":"Koch P","year":"2001","unstructured":"Koch P, del Valle F, Berdel WE, et al.. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01\/92. J Clin Oncol. 2001, 19:3861-73. 10.1200\/JCO.2001.19.18.3861","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900130305","article-title":"Prognostic factors for primary gastrointestinal lymphoma","volume":"13","author":"Liang R","year":"1995","unstructured":"Liang R, Todd D, Chan TK, et al.. Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol. 1995, 13:153-63. 10.1002\/hon.2900130305","journal-title":"Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.04.008","article-title":"Follicular lymphoma grade 3: review and updates","volume":"14","author":"Vaidyanathan G","year":"2014","unstructured":"Vaidyanathan G, Czuczman MS. Follicular lymphoma grade 3: review and updates. Clin Lymphoma Myeloma Leuk. 2014, 14:431-5. 10.1016\/j.clml.2014.04.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw400","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Dreyling M","year":"2016","unstructured":"Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016, 27:v83-90. 10.1093\/annonc\/mdw400","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.06.013","article-title":"Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy","volume":"44","author":"Maeshima AM","year":"2013","unstructured":"Maeshima AM, Taniguchi H, Nomoto J, et al.. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy. Hum Pathol. 2013, 44:2529-35. 10.1016\/j.humpath.2013.06.013","journal-title":"Hum Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire P","year":"2011","unstructured":"Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011, 17:697-707. 10.3748\/wjg.v17.i6.697","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25696","article-title":"Follicular lymphoma: 2020 update on diagnosis and management","volume":"95","author":"Freedman A","year":"2020","unstructured":"Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol. 2020, 95:316-27. 10.1002\/ajh.25696","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2018.14635","article-title":"Diagnosis and treatment of follicular lymphoma: an update","volume":"148","author":"Bargetzi M","year":"2018","unstructured":"Bargetzi M, Baumann R, Cogliatti S, et al.. Diagnosis and treatment of follicular lymphoma: an update. Swiss Med Wkly. 2018, 148:w14635. 10.4414\/smw.2018.14635","journal-title":"Swiss Med Wkly"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00340-z","article-title":"Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups","volume":"10","author":"Batlevi CL","year":"2020","unstructured":"Batlevi CL, Sha F, Alperovich A, et al.. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups. Blood Cancer J. 2020, 10:74. 10.1038\/s41408-020-00340-z","journal-title":"Blood Cancer J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0054","article-title":"NCCN Guidelines\u00ae Insights: B-cell lymphomas, version 5.2021","volume":"19","author":"Zelenetz AD","year":"2021","unstructured":"Zelenetz AD, Gordon LI, Chang JE, et al.. NCCN Guidelines\u00ae Insights: B-cell lymphomas, version 5.2021. J Natl Compr Canc Netw. 2021, 19:1218-30. 10.6004\/jnccn.2021.0054","journal-title":"J Natl Compr Canc Netw"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3282c9ad78","article-title":"Natural history of follicular grade 3 non-Hodgkin's lymphoma","volume":"19","author":"Bierman PJ","year":"2007","unstructured":"Bierman PJ. Natural history of follicular grade 3 non-Hodgkin's lymphoma. Curr Opin Oncol. 2007, 19:433-7. 10.1097\/CCO.0b013e3282c9ad78","journal-title":"Curr Opin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2298","article-title":"A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival","volume":"101","author":"Hans CP","year":"2003","unstructured":"Hans CP, Weisenburger DD, Vose JM, et al.. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood. 2003, 101:2363-7. 10.1182\/blood-2002-07-2298","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2798","article-title":"Significance of bulky mass and residual tumor-treated with or without consolidative radiotherapy-to the risk of relapse in DLBCL patients","volume":"9","author":"Tokola S","year":"2020","unstructured":"Tokola S, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O. Significance of bulky mass and residual tumor-treated with or without consolidative radiotherapy-to the risk of relapse in DLBCL patients. Cancer Med. 2020, 9:1966-77. 10.1002\/cam4.2798","journal-title":"Cancer Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0964-7","article-title":"Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy","volume":"89","author":"Song MK","year":"2010","unstructured":"Song MK, Chung JS, Sung-Yong O, et al.. Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy. Ann Hematol. 2010, 89:985-91. 10.1007\/s00277-010-0964-7","journal-title":"Ann Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325867","article-title":"Endoscopic diagnosis of follicular lymphoma with small-bowel involvement using video capsule endoscopy and double-balloon endoscopy: a case series","volume":"45","author":"Nakamura M","year":"2013","unstructured":"Nakamura M, Ohmiya N, Hirooka Y, et al.. Endoscopic diagnosis of follicular lymphoma with small-bowel involvement using video capsule endoscopy and double-balloon endoscopy: a case series. Endoscopy. 2013, 45:67-70. 10.1055\/s-0032-1325867","journal-title":"Endoscopy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0451-1","article-title":"A review of obinutuzumab (GA101), a novel type II anti-CD20 monoclonal antibody, for the treatment of patients with B-cell malignancies","volume":"34","author":"Tobinai K","year":"2017","unstructured":"Tobinai K, Klein C, Oya N, Fingerle-Rowson G. A review of obinutuzumab (GA101), a novel type II anti-CD20 monoclonal antibody, for the treatment of patients with B-cell malignancies. Adv Ther. 2017, 34:324-56. 10.1007\/s12325-016-0451-1","journal-title":"Adv Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.5089","article-title":"Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains","volume":"28","author":"Yahalom J","year":"2010","unstructured":"Yahalom J. Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains. J Clin Oncol. 2010, 28:4105-7. 10.1200\/JCO.2010.29.5089","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.02.007","article-title":"Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy","volume":"86","author":"Shi Z","year":"2013","unstructured":"Shi Z, Das S, Okwan-Duodu D, et al.. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys. 2013, 86:569-77. 10.1016\/j.ijrobp.2013.02.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31826c5907","article-title":"Chemotherapy alone for localized diffuse large B-cell lymphoma","volume":"18","author":"Sehn LH","year":"2012","unstructured":"Sehn LH. Chemotherapy alone for localized diffuse large B-cell lymphoma. Cancer J. 2012, 18:421-6. 10.1097\/PPO.0b013e31826c5907","journal-title":"Cancer J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000370096","article-title":"The role of consolidative radiotherapy after a complete response to chemotherapy in the treatment of diffuse large B-cell lymphoma in the rituximab era: results from a systematic review with a meta-analysis","volume":"134","author":"Hu C","year":"2015","unstructured":"Hu C, Deng C, Zou W, Zhang G, Wang J. The role of consolidative radiotherapy after a complete response to chemotherapy in the treatment of diffuse large B-cell lymphoma in the rituximab era: results from a systematic review with a meta-analysis. Acta Haematol. 2015, 134:111-8. 10.1159\/000370096","journal-title":"Acta Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89128-a-favorable-outcome-of-grade-3-follicular-lymphoma-treated-with-surgery-and-obinutuzumab-combined-with-chemotherapy-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:33Z","timestamp":1707507393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89128-a-favorable-outcome-of-grade-3-follicular-lymphoma-treated-with-surgery-and-obinutuzumab-combined-with-chemotherapy-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.23595","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,29]]}}}